SHFS vs MFIN vs ENVA vs LGND

For growth investors, Ligand Pharmaceuticals Incorporated (LGND) is the stronger pick with 27.

3% revenue growth year-over-year, versus -9. 2% for SHF Holdings, Inc. (SHFS). Medallion Financial Corp. (MFIN) offers the better valuation at 5. 4x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Enova International, Inc. (ENVA) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Medallion Financial Corp.

(MFIN) is the cheapest at 5. 4x versus Enova International, Inc. at 15. 1x. On forward P/E, Medallion Financial Corp. is actually cheaper at 8. 7x.

Over the past 5 years, Enova International, Inc.

(ENVA) delivered a total return of +374. 2%, compared to -99. 8% for SHF Holdings, Inc. (SHFS). Over 10 years, the gap is even starker: ENVA returned +20. 6% versus SHFS's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Ligand Pharmaceuticals Incorporated (LGND) is the lower-risk stock at 1.

03β versus SHF Holdings, Inc. 's 1. 83β — meaning SHFS is approximately 79% more volatile than LGND relative to the S&P 500. On balance sheet safety, Ligand Pharmaceuticals Incorporated (LGND) carries a lower debt/equity ratio of 1% versus 3% for Enova International, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Ligand Pharmaceuticals Incorporated (LGND) is pulling ahead at 27.

3% versus -9. 2% for SHF Holdings, Inc. (SHFS). On earnings-per-share growth, the picture is similar: Enova International, Inc. grew EPS 55. 9% year-over-year, compared to -114. 7% for SHF Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Medallion Financial Corp.

(MFIN) is the more profitable company, earning 12. 2% net margin versus -262. 5% for SHF Holdings, Inc. — meaning it keeps 12. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MFIN leads at 50. 5% versus -24. 2% for SHFS. At the gross margin level — before operating expenses — SHFS leads at 104. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Medallion Financial Corp.

(MFIN) trades at 8. 7x forward P/E versus 24. 6x for Ligand Pharmaceuticals Incorporated — 16. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LGND: 20. 9% to $267. 75.

In this comparison, MFIN (4.

7% yield) pays a dividend. SHFS, ENVA, LGND do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Medallion Financial Corp.

(MFIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 14), 4. 7% yield). SHF Holdings, Inc. (SHFS) carries a higher beta of 1. 83 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MFIN: +61. 7%, SHFS: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SHFS (Financial Services) and MFIN (Financial Services) and ENVA (Financial Services) and LGND (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SHFS is a small-cap quality compounder stock; MFIN is a small-cap high-growth stock; ENVA is a small-cap high-growth stock; LGND is a small-cap high-growth stock. MFIN pays a dividend while SHFS, ENVA, LGND do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.